Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. M. W. van de Garde, E. Hak, P. C. Souverein, A. W. Hoes, J. M. M. van den Bosch, H. G. M. Leufkens (Utrecht, Nieuwegein, Netherlands). Statin therapy and reduced risk of pneumonia in elderly patients with diabetes. Eur Respir J 2006; 28: Suppl. 50, 3073

Member's Comments

No comment yet.

Related content which might interest you: Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Impact of obesity on outcomes for patients hospitalised with pneumonia Source: Eur Respir J 2013; 41: 929-934 Year: 2013 Obesity and outcomes in patients hospitalized for pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012 Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Source: Eur Respir J 2015; 45: 463-472 Year: 2015 Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Budesonide is not associated with increased risk of pneumonia in COPD patients Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Particularities of pneumonia in diabetes patients. Source: Virtual Congress 2021 – Pneumonia Year: 2021 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Admission hyperglycaemia is associated with increased risk of diabetes mellitus following hospitalisation with community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007 Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019 Year: 2019 COPD medications and risk of pneumonia in the UK Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009